Ns Pharma, Inc.
Clinical trials sponsored by Ns Pharma, Inc., explained in plain language.
-
New pill could help people with rare Lung-Heart disease breathe easier
Disease control Not yet recruitingThis study is testing a new oral medication called NS-863 for adults with pulmonary arterial hypertension (PAH), a serious condition where high blood pressure in the lungs strains the heart. Researchers will compare three different doses of NS-863 against a placebo (inactive pill…
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New pill tested to ease strain on heart and lungs
Disease control Not yet recruitingThis study is testing an oral medication called NS-863 for adults with pulmonary hypertension caused by interstitial lung disease (PH-ILD), a condition where lung scarring makes the heart work harder. The main goal is to see if the drug safely reduces resistance in the lung's blo…
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC